What other stocks do shareholders of Actinogen Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Actinogen Medical investors own include Dynavax Technologies (DVAX) , Aldeyra Therapeutics (ALDX) , Ares Capital (ARCC) , BioCryst Pharmaceuticals (BCRX) , BioNTech (BNTX) , Centamin (CEY) , Countryside Partnerships (CSP) , Enbridge (ENB) , EQTEC (EQT) and Exact Sciences (EXAS) .

ASX:ACW

Actinogen Medical (ACW) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free ACW Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 275,000 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 8.76%
Price Target: N/A

Stock Analysis

Get Actinogen Medical alerts:

Ad InvestorPlace

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

About Actinogen Medical

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer's disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Ad InvestorPlace

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

ACW Stock News Headlines

April 15, 2024 | finanznachrichten.de

Actinogen Medical Limited: First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

April 15, 2024 | finance.yahoo.com

First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

March 12, 2024 | finance.yahoo.com

Investors in Actinogen Medical (ASX:ACW) have unfortunately lost 53% over the last year

February 28, 2024 | proactiveinvestors.com.au

Actinogen Medical delivers strong half-year results as it develops novel therapy

February 27, 2024 | au.investing.com

Actinogen Medical on track to deliver two key Phase 2 trial results in next 18 months

February 22, 2024 | msn.com

Diagnosing mental disorder through sleep: How TrivarX could capture this huge research market

January 30, 2024 | finance.yahoo.com

Will Actinogen Medical (ASX:ACW) Spend Its Cash Wisely?

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

January 24, 2024 | finance.yahoo.com

Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy

December 13, 2023 | morningstar.com

Actinogen Medical Ltd ACW

November 28, 2023 | finance.yahoo.com

Actinogen XanaCIDD Phase 2a trial in patients with depression and cognitive impairment: enrolment accelerating and on track for results in second quarter of 2024

November 10, 2023 | finance.yahoo.com

Shareholders May Be A Bit More Conservative With Actinogen Medical Limited's (ASX:ACW) CEO Compensation For Now

October 13, 2023 | finance.yahoo.com

Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston

September 26, 2023 | finance.yahoo.com

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update

May 31, 2023 | finance.yahoo.com

Actinogen to present progress on Cognitive Impairment in Depression and Alzheimer's Disease Phase 2 trials at the BIO International Convention

May 24, 2023 | travel.usnews.com

The 5 Best Travel Medical Insurance Plans for 2023

April 3, 2023 | uk.finance.yahoo.com

Investors in Actinogen Medical (ASX:ACW) have made a strong return of 215% over the past three years

March 30, 2023 | finance.yahoo.com

Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conference

March 27, 2023 | finance.yahoo.com

Actinogen Medical Limited (ATGGF)

January 12, 2023 | finance.yahoo.com

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

December 22, 2022 | finance.yahoo.com

FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial

December 14, 2022 | finance.yahoo.com

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

December 1, 2022 | reuters.com

Actinogen Medical Ltd

October 25, 2022 | uk.finance.yahoo.com

Investors in Actinogen Medical (ASX:ACW) have made a splendid return of 212% over the past three years

October 11, 2022 | benzinga.com

Actinogen Medical Stock (OTC:ATGGF), Earnings Estimates, EPS, and Revenue

October 10, 2022 | fool.com.au

Actinogen Medical share price crashes 67% lower on Alzheimer’s study results

See More Headlines

Receive ACW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Actinogen Medical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: ASX:ACW
CUSIP: N/A
CIK: N/A
Web: www.actinogen.com.au
Phone: 61 2 8964 7401
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-14,870,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -106.02%
Return on Assets: -59.24%

Debt

Debt-to-Equity Ratio: 0.37
Current Ratio: 5.42
Quick Ratio: 13.73

Sales & Book Value

Annual Sales: $4.79 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 2.38
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 2,330,000,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 2.28

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Dr. Steven G. Gourlay ) (Age 64)
FRACP, M.B.A., MBBS (M.D., Ph.D., MD, CEO & Director
Comp: $514.44k
Dr. Dana C. Hilt M.D. (Age 71)
Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board
Comp: $385.4k
Prof. Paul Rolan D.C.P.S.A.
F.F.P.M., F.R.A.C.P., M.B.B.S., M.D., Head of Clinical Pharmacology & Lead Physician and Depression
Mr. William Edward Souter BCom
IPAA, LLB (Adel), Chief Financial Officer
Mr. Michael Roberts
Head of Investor Relations & Corporate Communications
Dr. Fujun Li Ph.D.
Head of Manufacturing
Mr. Peter Gordon Webse B.Bus (Age 61)
FCIS, FCPA, FGIA, M.A.I.C.D., Company Secretary

Key Competitors

View All Competitors

Insiders

ACW Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Actinogen Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Actinogen Medical investors own include Dynavax Technologies (DVAX), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC), BioCryst Pharmaceuticals (BCRX), BioNTech (BNTX), Centamin (CEY), Countryside Partnerships (CSP), Enbridge (ENB), EQTEC (EQT) and Exact Sciences (EXAS).

This page (ASX:ACW) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial